A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH). 

Pharmaceutical

Inversago Pharma

Inversago Pharma's headquarters in Montreal, Canada

Karine Lalonde

Michael D. Harvey

Jianmin Duan

Jean-Daniel Bélanger

Micheline Beauvais

Michèle Desjardins

John Babetas

Sabina Bangash

Christine McCarthy

Arun J. Sanyal

Rohit N. Kulkarni

George Kunos

David Cherney

John J.P. Kastelein

Jean-Pierre Després

The Research and Development team at Inversago Pharma is dedicated to advancing innovative cannabinoid-1 receptor therapies through rigorous preclinical studies and clinical trials. Comprising experts in pharmacology, clinical operations, and regulatory affairs, the team collaborates to ensure the development of safe and effective treatments for metabolic disorders, such as Prader-Willi Syndrome, diabetes, and NASH, while adhering to quality and compliance standards.

Research and Development

The Leadership Team at Inversago Pharma drives the strategic direction and operational efficiency of the company, focusing on advancing the development of innovative cannabinoid therapies. Comprised of senior executives from key functional areas, including clinical operations, pharmacology, finance, and medical oversight, the team collaborates to align research priorities, secure funding, and ensure successful progression through preclinical stages, ultimately aiming to bring groundbreaking treatments to patients with metabolic disorders.

Leadership Team

The Regulatory and Compliance team at Inversago Pharma is responsible for ensuring that all development processes adhere to industry regulations and standards. They work closely with regulatory bodies to facilitate the approval of new cannabinoid-based therapies, manage compliance documentation, and oversee quality assurance practices to support the company's mission of advancing innovative treatments for metabolic disorders.

Regulatory and Compliance

��

Inversago Pharma

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Regulatory and Compliance

Offices

��������

Inversago Pharma

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Regulatory and Compliance

Offices

Related companies

��